| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 62.91B | 62.77B | 61.04B | 61.58B | 63.12B | 63.64B |
| Gross Profit | 15.62B | 15.34B | 14.72B | 14.84B | 16.32B | 17.02B |
| EBITDA | 4.63B | 4.02B | 3.42B | 1.65B | 3.93B | 4.76B |
| Net Income | 2.43B | 1.99B | 876.00M | -666.00M | 1.02B | 1.55B |
Balance Sheet | ||||||
| Total Assets | 55.22B | 56.58B | 57.97B | 57.70B | 58.23B | 57.11B |
| Cash, Cash Equivalents and Short-Term Investments | 7.75B | 7.74B | 7.21B | 7.87B | 8.10B | 6.47B |
| Total Debt | 12.33B | 13.58B | 14.92B | 15.69B | 13.51B | 12.45B |
| Total Liabilities | 25.77B | 27.20B | 29.85B | 30.82B | 29.73B | 29.07B |
| Stockholders Equity | 28.80B | 28.72B | 27.44B | 26.20B | 26.86B | 25.82B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.95B | -451.00M | -1.63B | 994.00M | 695.00M |
| Operating Cash Flow | 0.00 | 2.79B | 1.33B | -87.00M | 2.23B | 2.41B |
| Investing Cash Flow | 0.00 | -396.00M | -1.13B | -1.33B | -283.00M | -518.00M |
| Financing Cash Flow | 0.00 | -1.97B | -1.42B | 1.07B | -299.00M | -2.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥17.84B | 8.66 | ― | 3.62% | 7.07% | 79.18% | |
77 Outperform | ¥3.57B | 7.45 | ― | 1.93% | -1.00% | 105.56% | |
76 Outperform | ¥2.92B | 13.88 | ― | 4.01% | -2.33% | -68.46% | |
71 Outperform | ¥2.55B | 34.49 | ― | 1.68% | 3.07% | -32.45% | |
69 Neutral | ¥16.61B | 8.50 | ― | 3.79% | -0.03% | 84.08% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥5.77B | 19.83 | ― | 2.72% | -1.30% | ― |